Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;34(1):249-50.
doi: 10.1038/npp.2008.158.

Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?

Geoffrey T Swanson  1
Affiliations
Review

Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?

Geoffrey T Swanson. Neuropsychopharmacology. 2009 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE/CONFLICT OF INTEREST

The author has no conflicts of interest to disclose.

References

    1. Berry-Kravis E, Krause SE, Block SS, Guter S, Wuu J, Leurgans S, et al. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006;16:525–540. - PubMed
    1. Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling R. AMPA potentiator treatment of cognitive deficits in Alzheimer disease. Neurology. 2007;68:1008–1012. - PubMed
    1. Howes JF, Bell C. Talampanel. Neurotherapeutics. 2007;4:126–129. - PMC - PubMed
    1. Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol. 2006;6:82–88. - PubMed
    1. O’Neill MJ, Dix S. AMPA receptor potentiators as cognitive enhancers. IDrugs. 2007;10:185–192. - PubMed

MeSH terms